I-Mab, a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, announced...
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today announced...
Ryght, a leading healthcare technology company, announced the appointment of physician and author, Chadi Nabhan, MD, MBA, as its new Chief Medical Officer and...
Transcarent, a health and care experience company that makes it easy for people to access high-quality, affordable care announced that Dr. Randy Hawkins has...
